Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index; 37 of the 43 sources its claims cite were checked for support.

Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia

Open access
Sepulveda-Falla, Diego, Sanchez, Justin S., Almeida, Maria Camila, Boassa, Daniela, Acosta-Uribe, Juliana, Vila-Castelar, Clara, Ramirez-Gomez, Liliana, Baena, Ana, Aguillon, David, Villalba-Moreno, Nelson David, Littau, Jessica Lisa, Villegas, Andres, Beach, Thomas G., White, Charles L., Ellisman, Mark, Krasemann, Susanne, Glatzel, Markus, Johnson, Keith A., Sperling, Reisa A., Reiman, Eric M., Arboleda-Velasquez, Joseph F., Kosik, Kenneth S., Lopera, Francisco, Quiroz, Yakeel T. · 2022 · Acta Neuropathologica

Abstract

We describe in vivo follow-up PET imaging and postmortem findings from an autosomal dominant Alzheimer's disease (ADAD) PSEN1 E280A carrier who was also homozygous for the APOE3 Christchurch (APOE3ch) variant and was protected against Alzheimer's symptoms for almost three decades beyond the expected age of onset. We identified a distinct anatomical pattern of tau pathology with atypical accumulation in vivo and unusual postmortem regional distribution characterized by sparing in the frontal cortex and severe pathology in the occipital cortex. The frontal cortex and the hippocampus, less affected than the occipital cortex by tau pathology, contained Related Orphan Receptor B (RORB) positive neurons, homeostatic astrocytes and higher APOE expression. The occipital cortex, the only cortical region showing cerebral amyloid angiopathy (CAA), exhibited a distinctive chronic inflammatory microglial profile and lower APOE expression. Thus, the Christchurch variant may impact the distribution of tau pathology, modulate age at onset, severity, progression, and clinical presentation of ADAD, suggesting possible therapeutic strategies.

Overview

CoChat Summary

TL;DR

In a PSEN1 E280A carrier homozygous for the APOE3 Christchurch variant, longitudinal PET and postmortem analyses showed protection from Alzheimer’s dementia for almost three decades but a distinct tau pattern with occipital-predominant pathology and frontal sparing. Regional snRNA-seq linked less affected frontal and hippocampal areas to RORB-positive neurons, homeostatic astrocytes and higher APOE expression, while occipital cortex showed CAA, inflammatory microglia and lower APOE expression.

Key findings

  • The patient remained protected from Alzheimer’s symptoms for almost three decades beyond the expected age of onset; she was diagnosed with mild cognitive impairment at 72, mild dementia at 75, and died at 77 from metastatic melanoma.
  • Tau PET showed relative sparing of temporal and parietal neocortex with abnormally elevated occipital tau; annualized tau increases were entorhinal cortex 6.9%/year, amygdala 5.1%/year, and lateral occipital cortex 11.5%/year.
  • Postmortem brain weighed 894.3 g and was classified Braak VI, Thal V, CERAD C, A3B3C3; tau was highest in hippocampus, amygdala and occipital cortex (Brodmann areas 17 and 18) with negligible frontal tau, while Aβ showed a fronto-temporal predominant pattern and the occipital cortex was the only neocortical structure with CAA.
  • snRNA-seq identified RORB-positive neurons in frontal cortex and hippocampus; APOE expression showed a gradient from high in frontal cortex to low in occipital cortex, with astrocytic homeostatic genes correlating with APOE in frontal cortex/hippocampus and microglial immune-response genes correlating in occipital cortex.

Methods

  • Case report with longitudinal clinical assessments, structural MRI, 11C-Pittsburgh Compound B and 18F-Flortaucipir PET at ages 73 and 75, compared with typical PSEN1 E280A carriers and older sporadic AD patients.
  • Postmortem neuropathology at age 77 examined 17 brain regions with H&E and immunohistochemistry for Aβ, hyperphosphorylated tau, Iba1, TMEM119, CD68, GFAP, RORB and ApoE, plus electron microscopy and ImageJ quantification with Spearman correlation analyses.
  • Single-nuclei RNA sequencing was performed on frontal cortex, hippocampus and occipital cortex using 10x Chromium; data were processed in Seurat with clustering, differential expression, APOE correlation and gene ontology analyses, and microglial signatures were compared with published acute and chronic neurodegenerative profiles.

Limitations

  • The paper states the most prominent limitation is that findings are based on analyses of one case, and that mere associations cannot address causal connections by themselves.
  • The paper notes that locating another ADAD case homozygous for the APOE3ch variant might be very challenging, and that further studies involving more protected patients would be ideal to compare and validate the findings.
  • The paper also states that gene expression does not necessarily represent actual protein levels and that further studies would be necessary to confirm the pathways involved.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00401-022-02467-8

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Longitudinal tau PET imaging measures in an APOE3ch homozygote. A Surface rendering of tau PET (Flortaucipir) images (standardized uptake value ratio, SUVr), at baseline, 3-year follow-up (center), and B rate of change (expressed as %/year), in the APOE3ch homozygote, (left) a typical PSEN1-E280A impaired carrier (center) and a sporadic AD case (right). C Distribution area plot showing annualized percent change rates in tau PET for APOE3ch homozygote (red line) relative to unimpaired (blue) and impaired (green) PSEN1-E280A carriers. Regions along the x-axis are ordered from highest to lowest change rate observed in the APOE3ch homozygote. D Spaghetti plots of Aβ PET (Pittsburgh Compound B, PiB) measurements at baseline and 2-year follow-up, E Structural MRI measurements at baseline and 2-year follow-up of hippocampal volume
Fig. 1 Longitudinal tau PET imaging measures in an APOE3ch homozygote. A Surface rendering of tau PET (Flortaucipir) images (standardized uptake value ratio, SUVr), at baseline, 3-year follow-up (center), and B rate of change (expressed as %/year), in the APOE3ch homozygote, (left) a typical PSEN1-E280A impaired carrier (center) and a sporadic AD case (right). C Distribution area plot showing annualized percent change rates in tau PET for APOE3ch homozygote (red line) relative to unimpaired (blue) and impaired (green) PSEN1-E280A carriers. Regions along the x-axis are ordered from highest to lowest change rate observed in the APOE3ch homozygote. D Spaghetti plots of Aβ PET (Pittsburgh Compound B, PiB) measurements at baseline and 2-year follow-up, E Structural MRI measurements at baseline and 2-year follow-up of hippocampal volumeCC BY · PubMed Central
Fig. 2 Neuropathological and molecular characterization of an ADAD PSEN1E280A mutation carrier with two copies of the APOE3ch variant. A Representative panels for tau and Aβ pathology in frontal cortex, hippocampus, and occipital cortex. Insets show specific pathological features found in each brain area, such as NFT, dystrophic neurites and diffuse tau pathology, together with diffuse, core Aβ plaques and CAA. Bar = 500 µm. B Graphic representation of general distribution and intensity of tau pathology signal with normalized lower and maximum values represented in red intensity. MFC medial frontal cortex, STC superior temporal cortex, MTC middle temporal cortex, ITC inferior temporal cortex, HIP hippocampus, AMY amygdala, CNG cingulate cortex, PUT putamen, CAU caudate, THA thalamus, IPC inferior parietal cortex, OL occipital lobe, CB cerebellum, MES mesencephalon, PON pons, MED medulla oblongata. C Graphic representation of distribution and intensity of Aβ signal with normalized lower and maximum values represented in green intensity. D Distribution area plot showing tau integrated density signal in cortical areas in APOE3ch homozygote (red line) relative to impaired (green) PSEN1-E280A carriers. Areas are ordered according to the highest to lowest tau integrated density in the APOE3ch homozygote. E Correlation scatter plot for ApoE signal intensity against Iba1 signal intensity in all areas studied in B. A positive correlation was identified as statistically significant. (**p ≤ 0.01). F UMAP clustering plot of snRNA sequencing data from the frontal cortex (FC, red dots), hippocampus (HIP, green dots) and occipital cortex (OL, blue dots). Identified clusters include excitatory neurons (Exc 1, 2 and 3), oligodendrocyte precursor cells (OPCs), microglia (Mic), RORB positive neurons (RORB + 1 and 2), inhibitory neurons (Inh 1 and 2), endothelial cells (End), oligodendrocytes (Olig) and astrocytes (Ast). G UMAP clustering plot of snRNA sequencing data from the analyzed areas depicting RORB expression levels in the different clusters. H Violin plots for differential expression of representative genes between excitatory neurons and RORB + neurons clusters. Excitatory clusters differentially express functional synaptic genes while RORB1 clusters express neuronal development genes. I Violin plots for APOE expression in FC, HIP and OL in astrocytes and microglia. J Top gene ontology terms from overrepresented genes positively correlating with APOE expression in astrocytes from frontal cortex, hippocampus and occipital cortex. K Top gene ontology terms from overrepresented genes positively correlating with APOE expression in microglia from frontal cortex, hippocampus and occipital cortex
Fig. 2 Neuropathological and molecular characterization of an ADAD PSEN1E280A mutation carrier with two copies of the APOE3ch variant. A Representative panels for tau and Aβ pathology in frontal cortex, hippocampus, and occipital cortex. Insets show specific pathological features found in each brain area, such as NFT, dystrophic neurites and diffuse tau pathology, together with diffuse, core Aβ plaques and CAA. Bar = 500 µm. B Graphic representation of general distribution and intensity of tau pathology signal with normalized lower and maximum values represented in red intensity. MFC medial frontal cortex, STC superior temporal cortex, MTC middle temporal cortex, ITC inferior temporal cortex, HIP hippocampus, AMY amygdala, CNG cingulate cortex, PUT putamen, CAU caudate, THA thalamus, IPC inferior parietal cortex, OL occipital lobe, CB cerebellum, MES mesencephalon, PON pons, MED medulla oblongata. C Graphic representation of distribution and intensity of Aβ signal with normalized lower and maximum values represented in green intensity. D Distribution area plot showing tau integrated density signal in cortical areas in APOE3ch homozygote (red line) relative to impaired (green) PSEN1-E280A carriers. Areas are ordered according to the highest to lowest tau integrated density in the APOE3ch homozygote. E Correlation scatter plot for ApoE signal intensity against Iba1 signal intensity in all areas studied in B. A positive correlation was identified as statistically significant. (**p ≤ 0.01). F UMAP clustering plot of snRNA sequencing data from the frontal cortex (FC, red dots), hippocampus (HIP, green dots) and occipital cortex (OL, blue dots). Identified clusters include excitatory neurons (Exc 1, 2 and 3), oligodendrocyte precursor cells (OPCs), microglia (Mic), RORB positive neurons (RORB + 1 and 2), inhibitory neurons (Inh 1 and 2), endothelial cells (End), oligodendrocytes (Olig) and astrocytes (Ast). G UMAP clustering plot of snRNA sequencing data from the analyzed areas depicting RORB expression levels in the different clusters. H Violin plots for differential expression of representative genes between excitatory neurons and RORB + neurons clusters. Excitatory clusters differentially express functional synaptic genes while RORB1 clusters express neuronal development genes. I Violin plots for APOE expression in FC, HIP and OL in astrocytes and microglia. J Top gene ontology terms from overrepresented genes positively correlating with APOE expression in astrocytes from frontal cortex, hippocampus and occipital cortex. K Top gene ontology terms from overrepresented genes positively correlating with APOE expression in microglia from frontal cortex, hippocampus and occipital cortexCC BY · PubMed Central

Verification

Claims the paper makes

28 Valid · 0 Not valid · 3 Not checked · 104 Own results and interpretations

63 more claims · 4 with their cited sources checked

Create a free account to see all 135 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 30
  • It may state two separate claims as one. 47

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

20 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 39 references

Cited by

See all 94

Metadata

Authors
Sepulveda-Falla, D., Sanchez, J. S., Almeida, M. C., Boassa, D., Acosta-Uribe, J., Vila-Castelar, C., Ramirez-Gomez, L., Baena, A., Aguillon, D., Villalba-Moreno, N. D., Littau, J. L., Villegas, A., Beach, T. G., White, C. L., Ellisman, M., Krasemann, S., Glatzel, M., Johnson, K. A., Sperling, R. A., Reiman, E. M., Arboleda-Velasquez, J. F., Kosik, K. S., Lopera, F., & Quiroz, Y. T.
Affiliations
  • Harvard University (US)
  • University of California, Santa Barbara (US)
  • University of California San Diego (US)
  • Universidad de Antioquia (CO)
  • University Medical Center Hamburg-Eppendorf (DE)
  • Banner Sun Health Research Institute (US)
  • The University of Texas Southwestern Medical Center (US)
  • Banner Alzheimer’s Institute (US)
Corresponding author
Quiroz, Yakeel T.
Venue
Acta Neuropathologica
Published
2022-07-15
Volume
144
Issue
3
Pages
589-601
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W4285589271
Cited by
92
References
39
Citations by year
2026: 10 · 2025: 24 · 2024: 31 · 2023: 22 · 2022: 4
FWCI
12.52
Type
journal article
Language
en
Open access
Licence
Locations
  • Acta Neuropathologica (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repository University of Antioquia (University of Antioquia) (submittedVersion, cc-by)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Greater South Information System
Funders
  • National Institute of Aging (R01 AG054671)
  • Massachusetts General Hospital Executive Committee on Research
  • Alzheimer’s Association Research Grant
  • Deutsche Forschungsgemeinschaft (CellNetFAD # 458854216)
  • National Institute of Neurological Disorders and Stroke (RF1 NS110048, UH3 NS100121)
  • Alzheimer’s Association Research Fellowship
  • Universidad de Antioquia
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/22819-8)
  • Werner Otto Stiftung
  • Bundesministerium für Bildung und Forschung (UndoAD)
  • Universitätsklinikum Hamburg-Eppendorf (UKE)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
autosomal dominant Alzheimer's disease, tau pathology, cerebral amyloid angiopathy, occipital cortex, RORB, microglial inflammation, age of onset, disease progression, positron emission tomography
MeSH terms
Alzheimer Disease, Brain, Homozygote, Humans, Amyloid beta-Peptides, tau Proteins, Positron-Emission Tomography, Apolipoprotein E3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia. https://app.cochat.ai/papers/10.1007/s00401-022-02467-8
The paper
Sepulveda-Falla, D., Sanchez, J. S., Almeida, M. C., Boassa, D., Acosta-Uribe, J., Vila-Castelar, C., Ramirez-Gomez, L., Baena, A., Aguillon, D., Villalba-Moreno, N. D., Littau, J. L., Villegas, A., Beach, T. G., White, C. L., Ellisman, M., Krasemann, S., Glatzel, M., Johnson, K. A., Sperling, R. A., . . . Quiroz, Y. T. (2022). Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia. Acta Neuropathologica. https://doi.org/10.1007/s00401-022-02467-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.